Antengene Presents Encouraging Clinical Data from Four Pipel

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...

Related Keywords

China , South Korea , Taiwan , Australia , Hong Kong , Beijing , Singapore , Shanghai , Chinese , Peter Qian , Jay Mei , Asia Pacific , Antengene Corporation Limited , Company Annual , Antengene Corporation , Md Anderson Cancer Center , Antengene Shanghai Office , Hong Kong Stock Exchange , Family Zhang , Chief Medical , Cancer Center , Corporation Limited , Patients Beyond , Taiwan China , Hong Kong China , Annual Report , Hong Kong Stock , Health Care Amp Hospitals , Medical Pharmaceuticals , Biotechnology , Pharmaceuticals , Clinical Trials Amp Medical Discoveries , Surveys , Olls And Research ,